Printer Friendly

Cmed Clinical Services Showcases New in-House Drug Development Consulting, Regulatory and Medical Affairs Group at DIA 2012.

HORSHAM, England -- Cmed Clinical Services, the global CRO specialised in the design and delivery of traditional and innovative pre-phase III clinical trials, announces the creation of its new Medical and Regulatory Affairs Group. Experienced professionals from across the industry have been brought together to create this team, in order to supplement the company's mission to become recognized as the early pre-phase III clinical trial specialists.

Led by Geoff Fatzinger, Vice President of Global Medical and Regulatory Affairs, the depth and breadth of experience within this group allows Cmed to provide strategic drug development consulting to biopharmaceutical companies. Further, Cmed's Medical and Regulatory Affairs group provides expansive global expertise as an independent consulting team or by working alongside the client's own management from "concept to commercialization" and beyond. It provides a comprehensive suite of services to meet client demands, including product development of devices, biological and pharmaceutical products through to the post marketing arena. The team has extensive experience in providing due diligence programs and full pharmacovigilance services for licensed and unlicensed products.

The DIA's 2012 Annual Meeting (June 24-28, Philadelphia, PA) provides the perfect platform to showcase the company's enhancing service offering to both existing and prospective clients.

Visitors to Booth 3315 will have the unique opportunity to learn about Cmed's specialized solution. Geoff Fatzinger, Vice President of Global Medical and Regulatory Affairs, and Helen Yong, Drug Safety Officer, will be on hand to provide valuable insight and advice to individuals and companies on topics such as product development strategies, global regulatory strategies, PvG strategies, and best practices.

To pre-book an informative discussion with Geoff or Helen on Tuesday 26th or Wednesday 27th June at DIA 2012, please email:

- ends -

About Cmed Clinical Services

Cmed Clinical Services is a long-established, flexible CRO with offices in the UK, US and Romania offering project management, clinical monitoring, data management, biostatistics, medical and regulatory affairs, and medical writing. Through the coupling of our own proprietary e-clinical technology, Timaeus, with our study delivery teams, Cmed Clinical Services has distinctive capabilities which enables us to deliver early phase I to IIb clinical projects innovatively; faster and more cost effectively. To learn more, visit
COPYRIGHT 2012 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 18, 2012
Previous Article:SmartDeploy to Host Webcast on Hidden Costs Associated with Windows Deployment.
Next Article:Fitch to Assign 'AA+/F1' Rtg to So. California Pub Power Auth's (Palo Verde Proj) 2008A&B Bonds.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters